This is a preview of subscription content, log in via an institution to check access.
REFERENCE
COLLINS CD, Stuntebeck ER, DePestel DD, Stevenson JG.Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia. Clinical Drug Investigation 27: 233-241, No. 4, 2007
Wingard JR, Leather HL, Wood CA, Gerth WC, Lupinacci RJ, Berger ML, Mansley EC.Pharmacoeconomic analysis of caspofungin versus liposomal amphotericin B as empirical antifungal therapy for neutropenic fever. American Journal of Health-System Pharmacy 64: 637-643, No. 6, 15 Mar 2007
Rights and permissions
About this article
Cite this article
Liposomal amphotericin B poor value for febrile neutropenia. Pharmacoecon. Outcomes News 529, 9 (2007). https://doi.org/10.2165/00151234-200705290-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705290-00024